Tag: Daliresp

Roflumilast is a powerful anti-inflammatory medication that requires a doctor's prescription for all its formulations, both oral and topical. Answering the question, "**Is roflumilast available over the counter?**," with a definitive 'no' is crucial for patient safety. This guide explores why this potent drug, used for conditions like severe COPD and psoriasis, is not suitable for OTC use.

As of February 2022, the FDA approved a generic version of the brand-name drug Daliresp. This makes it possible for patients to obtain a more affordable option for their severe Chronic Obstructive Pulmonary Disease (COPD) treatment, which can help lower the risk of exacerbations.

In the U.S., an estimated 30% to 50% of adults with Chronic Obstructive Pulmonary Disease (COPD) experience at least one flare-up annually. For those with severe COPD, the question often arises: **what does DALIRESP do for COPD?** This oral medication is designed to decrease the frequency of these exacerbations.

Following the release of its generic equivalent, roflumilast, in early 2022, the price landscape for the brand-name COPD medication Daliresp has shifted significantly, though retail costs remain high. For patients, understanding how much is Daliresp and how to manage its expense is crucial, requiring a look at insurance, manufacturer programs, and discount options.